1. Home
  2. ESPR vs GCMG Comparison

ESPR vs GCMG Comparison

Compare ESPR & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.29

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Logo GCM Grosvenor Inc.

GCMG

GCM Grosvenor Inc.

HOLD

Current Price

$11.63

Market Cap

731.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
GCMG
Founded
2008
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
793.7M
731.1M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ESPR
GCMG
Price
$3.29
$11.63
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$7.20
$15.67
AVG Volume (30 Days)
2.9M
678.5K
Earning Date
04-02-2026
01-01-0001
Dividend Yield
N/A
4.14%
EPS Growth
86.21
N/A
EPS
N/A
N/A
Revenue
$332,314,000.00
N/A
Revenue This Year
$27.35
$7.28
Revenue Next Year
N/A
$11.70
P/E Ratio
N/A
$28.21
Revenue Growth
185.66
N/A
52 Week Low
$0.73
$9.86
52 Week High
$4.18
$13.71

Technical Indicators

Market Signals
Indicator
ESPR
GCMG
Relative Strength Index (RSI) 43.62 53.87
Support Level $3.16 $11.36
Resistance Level $3.41 $11.98
Average True Range (ATR) 0.14 0.56
MACD -0.01 0.05
Stochastic Oscillator 5.75 59.72

Price Performance

Historical Comparison
ESPR
GCMG

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About GCMG GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

Share on Social Networks: